To illustrate how green this team is Kain said they wouldn't spend $10m for an independent audit as it would be too expensive. They've lost over $100m in shareholder value since then (and $550m since the Glaucus report was released)
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025